Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4584853
Max Phase: Preclinical
Molecular Formula: C22H23N7O
Molecular Weight: 401.47
Molecule Type: Unknown
Associated Items:
ID: ALA4584853
Max Phase: Preclinical
Molecular Formula: C22H23N7O
Molecular Weight: 401.47
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1cn2nc(-c3cc(=O)n4cc(N5CCN6CCC[C@H]6C5)ccc4n3)ccc2n1
Standard InChI: InChI=1S/C22H23N7O/c1-15-12-29-21(23-15)7-5-18(25-29)19-11-22(30)28-14-17(4-6-20(28)24-19)27-10-9-26-8-2-3-16(26)13-27/h4-7,11-12,14,16H,2-3,8-10,13H2,1H3/t16-/m0/s1
Standard InChI Key: YXFPYQSJPBUTNI-INIZCTEOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 401.47 | Molecular Weight (Monoisotopic): 401.1964 | AlogP: 2.00 | #Rotatable Bonds: 2 |
Polar Surface Area: 71.04 | Molecular Species: BASE | HBA: 8 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.07 | CX LogP: 1.13 | CX LogD: -0.55 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.51 | Np Likeness Score: -1.94 |
1. Ratni H, Ebeling M, Baird J, Bendels S, Bylund J, Chen KS, Denk N, Feng Z, Green L, Guerard M, Jablonski P, Jacobsen B, Khwaja O, Kletzl H, Ko CP, Kustermann S, Marquet A, Metzger F, Mueller B, Naryshkin NA, Paushkin SV, Pinard E, Poirier A, Reutlinger M, Weetall M, Zeller A, Zhao X, Mueller L.. (2018) Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)., 61 (15): [PMID:30044619] [10.1021/acs.jmedchem.8b00741] |
Source(1):